Efficacy and safety of Telitacicept in patients with IgA nephropathy

  • Dongrui Liang
  • Xiaodong Li
DOI: https://doi.org/10.12669/pjms.39.6.8393
Keywords: IgA nephropathy, Chronic kidney disease, Telitacicept

Abstract

doi: https://doi.org/10.12669/pjms.39.6.8393

How to cite this: Liang D, Li X. Efficacy and safety of Telitacicept in patients with IgA nephropathy. Pak J Med Sci. 2023;39(6):1897.  doi: https://doi.org/10.12669/pjms.39.6.8393

Author Biographies

Dongrui Liang

 

 

Xiaodong Li

 

 

 

Published
2023-09-23
How to Cite
Liang, D., & Li, X. (2023). Efficacy and safety of Telitacicept in patients with IgA nephropathy. Pakistan Journal of Medical Sciences, 39(6). https://doi.org/10.12669/pjms.39.6.8393
Issue
Vol. 39 No. 6 (2023): November - December 2023
Section
Correspondence